Fischer, C <br/><br/>
[Analysis of cardiovascular diseases after the upload phase with intravitreal ranibizumab and bevacizumab in patients with exudative age-related macular degeneration].  [electronic resource] 

 -  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft  Jul 2016 
 - 589-95 p.  digital 
<br/><br/> Publication Type: Clinical Study; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1433-0423 
<br/><br/><label>Standard No.: </label>10.1007/s00347-015-0214-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angina Pectoris--chemically induced<br/>Bevacizumab--adverse effects<br/>Female<br/>Humans<br/>Hypertension--chemically induced<br/>Intravitreal Injections<br/>Macular Degeneration--drug therapy<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Ranibizumab--adverse effects<br/>Risk Factors<br/>Stroke--chemically induced<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors